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Abstract
To verify that the Korean Diabetes Score (KDS), a self-assessment, predicts the risk of diabetes in various comprehensive risk
models, and to investigate factors that enhance its predictive ability in a large cohort. We analyzed 8735 adults without diabetes in the
Korean Genome and Epidemiology Study, an ongoing large community-based 10-year cohort study. Incident diabetes was deﬁned
as fasting blood glucose ≥126mg/dL or postload 2-hour glucose ≥200mg/dL by 75g oral glucose tolerance test conducted
biennually, or currently taking medication for diabetes. Hazard ratios (HRs) using Cox regression were calculated for relative risk of
developing diabetes as associatedwith the KDS, and performance of riskmodels was assessed by area under the receiver-operating
characteristic curve (AUC). Of 8735 participants, 1497 (17.1%) developed diabetes over 10 years. The prevalence of incident
diabetes was 10.3% in people with a KDS <5 and was 21.8% in those with KDS ≥5 (P< .001). Increasing KDS was signiﬁcantly
associated with developing diabetes (adjusted HR: 1.13; 95% conﬁdence interval:1.09,1.18). The comprehensive prediction model
with KDS added to fasting glucose, glycated hemoglobin, postload 2-hour glucose, and triglyceride showed a markedly higher AUC
(0.782) compared to KDS alone (0.641). A low insulinogenic index (IGI) level, but not insulin resistance, was a signiﬁcant determinant
of developing diabetes in subjects who had baseline KDS<5. We conﬁrmed that KDS as a 10-year risk model to predict diabetes
becomes more potent when added to relevant laboratory parameters. Beta-cell function as assessed by IGI should be taken into
account when predicting diabetes using the KDS.
Abbreviations: AUC = area under the receiver-operating characteristic curve, BMI = body mass index, CI = conﬁdence interval,
DM = diabetes mellitus, HbA1c = glycated hemoglobin, HDL = high-density lipoprotein, HOMA-IR = homeostasis model
assessment of insulin resistance, HR = hazard ratio, IGI = insulinogenic index, KDS = Korean Diabetes Score, KoGES = Korean
Genome and Epidemiology Study, OGTT = oral glucose tolerance test, ROC = receiver-operating characteristic, SBP = systolic
blood pressure.
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[2]1. Introduction
Type 2 diabetes mellitus (DM), a major health problem, is
increasing worldwide.[1] The estimated 382 million people with
diabetes in 2013 is predicted to rise to 592 million by 2035Editor: Xiaolin Zhu.
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1globally. In the United States, the estimated prevalence of
diabetes is 12% to 14% among adults in the overall popula-
tion.[3] The prevalence of diabetes in the Western Paciﬁc region is
also increasing rapidly and is expected to exceed 202 million by
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Kim et al. Medicine (2017) 96:23 Medicinelifestyle and epigenetics. Diabetes has been associated with
chronic metabolic conditions such as obesity and metabolic
syndrome, as well as related macrovascular and microvascular
complications.[6] Consequently, these complications and mortal-
ity represent an increasing burden on socioeconomic and public
healthcare systems.[7,8] Therefore, a focus on prevention and
early detection of diabetes is urgently needed.
A number of diabetes risk scoring models have been
developed.[9–12] Because these risk scoring models are designed
primarily for Western people, and because the pathophysiology
of Type 2 DM is different in Asians, these methods may not be
suitable.[13] Moreover, because more than 60% of people with
diabetes live in Asian countries and have a great impact on global
epidemic,[14] it is critical to focus on the development of diabetes
in Asians. Therefore, the KDS was developed to assess the risk of
diabetes in Koreans without requiring any blood tests.[15]
However, it has not been fully validated to predict diabetes in
a large prospective cohort. Therefore, we aimed to investigate
and validate not only the KDS but also a comprehensive risk
model combining laboratory variables as useful tools for
predicting diabetes in a 10-year longitudinal cohort of 10,030
people in Korea. In addition, we also sought to identify risk
factors for diabetes in low-risk people with low KDS scores at
baseline who ultimately develop diabetes, to predict incident
diabetes.2. Methods
2.1. Study population
The Korean Genome and Epidemiology Study (KoGES) is an
ongoing prospective study that enrolled 10,030 participants aged
40 to 69 years who live in urban Ansan or rural Ansung
communities in the Republic of Korea. Begun in 2001, for
baseline recruitment, eligible participants were recruited as
volunteers through on-site invitation, telephone calls, letters,
media campaign, or community conferences.[16] The KoGES
includes results of biennial self-reported questionnaires regarding
medical history, family history, smoking and alcohol consump-
tion, and exercise status and health examinations by trained staff
at the survey sites, including national medical schools, hospitals,
and health institutions. Exclusion criteria in this study are:
current steroid users (N=15), individuals with previously
diagnosed diabetes or any oral hypoglycemic agents or insulin
(N=682), missing results from a 75g oral glucose tolerance test
(OGTT) (N=45), and participants with fasting glucose concen-
tration ≥126mg/dL or a postload 2-hour glucose concentration
by a 75-g OGTT≥200mg/dL (N=553) (Supplementary Fig. 1,
http://links.lww.com/MD/B726). Ultimately, a total of 8735
individuals were analyzed in the present study. Among 8735
participants at baseline, 5549 individuals were successfully
followed up to Year 10. This study was approved by the Korean
Center for Disease Control and Prevention and the Institutional
Review Board of the Severance Hospital (IRB No: 4-2014-0508).2.2. Data and measurements
Baseline measurements of height, weight, and waist circumfer-
ence were obtained. Body mass index (BMI) was calculated as kg/
m2 from measured height and weight. Obesity was deﬁned as
BMI≥25kg/m2 by criteria of the Asian and Paciﬁc regions.[17–19]
Blood pressure was measured 3 times in the morning, after at
least 10 minutes in the sitting position. Hypertension was2diagnosed in subjects who were taking hypertension medication
or a measured blood pressure ≥140/90mm Hg. Smoking and
alcohol consumption were categorized into 3 categories as never,
past smoker, or current smoker, and none, <1, 1–4.9, or ≥5
drinks per day, respectively. Exercise status was stratiﬁed into 3
groups according to frequency of exercise (none, 1–3 times, or≥4
times weekly). After a 12-hour fast, plasma total cholesterol,
triglyceride, and high-density lipoprotein (HDL) cholesterol were
determined using a 747 chemistry analyzer (Hitachi Ltd, Tokyo,
Japan). Low-density lipoprotein cholesterol level was calculated
by the Friedewald equation: total cholesterol-HDL cholesterol-
triglycerides/5. In a 75-gOGTT, plasma glucose and insulin levels
at 0, 60, and 120min were measured by using the hexokinase
method and radioimmunoassay (LINCO kit, St Charles, MO),
respectively. Glycated hemoglobin (HbA1c) level was measured
by high-performance liquid chromatography (Variant II; Bio-Rad
Laboratories, Hercules, CA). In this study, the diagnostic criteria
for incident diabetes was current oral hypoglycemic agents or
insulin, a fasting glucose level ≥126mg/dL, or a postload 2-hour
glucose level ≥200mg/dL by biannually conducted 75-g OGTT,
based on the American Diabetes Association criteria.[20] Homeo-
stasis model assessment of insulin resistance (HOMA-IR) and
60 minutes insulinogenic index (IGI) were calculated using the
following indices: fasting plasma insulin (mIU/mL) fasting
plasma glucose (mg/dL)/405 and (postload 60-minute insulin
fasting insulin [mIU/mL])/(postload 60-minute glucose fasting
glucose [mmol/L]), respectively.[21,22] Criteria for diagnosis of
metabolic syndrome according to the revisedNational Cholesterol
Education Program deﬁnition were 3 or more of the following:
waist circumference >90cm in men or >80cm in women;
serum triglycerides ≥150mg/dL or medication use; HDL choles-
terol level <40mg/dL in men or <50mg/dL in women; blood
pressure ≥130/85mm Hg or hypertension medication use; or
serum fasting glucose ≥100mg/dL or diabetes medication
use.[23,24]2.3. Korean diabetes score
Points for the Korean Diabetes Score (KDS) were assessed by
following criteria as previously described[15,25]: age: <35 years
old was determined as 0, 35–44 years old as 2, and ≥45 years old
as 3; waist circumference: percentiles 1–50 were determined as 0,
percentiles 51–74 as 2, and >75 as 3; alcohol consumption per
day: <1 drink was determined as 0, 1–4.9 drinks as 1, and ≥5
drinks as 2; and family history of diabetes, history of
hypertension, and smoking status were determined as 0 or 1.
KDS score ≥5 was regarded as a cut point for being at high risk
for diabetes.[15]2.4. Statistical analyses
Data are presented as means± standard deviations or frequencies
with percentages. Differences were analyzed using Chi-square
tests for categorical variables and Student t tests or 1-way analysis
of variance followed by the Tukey honestly signiﬁcant difference
post hoc test for multiple comparisons, for continuous variables.
Cox proportional hazard analysis was performed to estimate
whether the KDS was associated with incident diabetes and to
determine the independent relationship of the variables for
developing diabetes. Cumulative event rates for developing
diabetes were accessed by Kaplan–Meier survival curves, and
equality was compared with the log-rank test. To compare the
combined effect of using the KDS and various parameters for
Kim et al. Medicine (2017) 96:23 www.md-journal.compredicting incident diabetes, we evaluated receiver-operating
characteristic (ROC) curves and the areas under the receiver-
operating characteristic curves (AUCs) as a discrimination index.
For the comparison of ROC curves between various models,
DeLong methods were used.[26] A P< .05 was considered
statistically signiﬁcant. Statistical analyses were performed using
PASW Statistics version 20.0 for Windows (SPSS Inc., Chicago,
IL) and MedCalc software for Windows (Version 13.1, Ostend,
Belgium).3. Results
3.1. Clinical and laboratory characteristics of participants
at baseline
The mean age of participants was 51.7±8.8 years; 53.3% were
women, and the mean BMI was 24.5±3.0kg/m2. Of these 8735
participants, 1513 (17.3%) progressed to diabetes during the 10-
year follow-up period. There were 3388 (38.8%) participants
with a KDS<5 and 5347 (61.2%) had a KDS≥5 at baseline.
Participants’ baseline clinical and laboratory characteristics
according to presence of incident diabetes during the follow-
up period and a cut point of KDS of 5 are shown in Table 1.
Individuals with incident diabetes or a KDS≥5 tended to be
older, more likely to be men, more obese, more hypertensive, to
have more family history of diabetes, more likely to smoke, and
to have metabolically unhealthy parameters compared to those
with nondiabetes or KDS<5. When compared to individuals
with a KDS≥5 who ultimately did not develop diabetes, those
with KDS<5, but ultimately develop diabetes, showed signiﬁ-
cant younger ages, lower BMI, less hypertensive, less likely to
smoke or drink, less likely to have metabolic syndrome, but withTable 1
Baseline characteristics of the subjects according to KDS score and
Nondiabetes (N=7222)
KDS<5 (N=3039) KDS≥5 (N
Age, y †48.7±8.4 ‡53.4±
Female, n (%) jj1666 (54.8) ¶2261
Waist circumference, cm †74.6±5.6 ‡86.5±
BMI, kg/m2 jj22.5±2.3 ‡25.6±
Obesity, n (%) a395 (13.2) ‡2307
Hypertension, n (%) †301 (9.9) ‡1546
SBP, mm Hg †112.7±15.2 ‡124.0±
DBP, mm Hg †75.0±10.1 ‡82.3±
Family history of diabetes, n (%) jj215 (7.1) 487 (1
Smoking, never/past/current, n (%) 1963/495/581 (64.6/16.3/19.1) 2457/526/1200 (
Alcohol, 1/1–4.9/≥5 drinks/d, n (%) 2775/257/7 (91.3/8.5/0.2) 3132/801/250 (
Exercise, none/1–3/≥4 times/wk, n (%) 2175/604/260 (71.6/19.9/8.6) 3075/806/302 (
Metabolic syndrome, n (%) jj130 (4.3) ‡1568
HbA1c, % †5.5±0.3 ‡5.6±
Fasting glucose, mg/dL †80.9±7.5 ‡82.8±
Postload 2-h glucose, mg/dL †108.0±27.9 ‡112.8±
Fasting insulin, mIU/ mL 6.7±4.0 ¶8.0±
Postload 2-h insulin, mIU/ mL jj24.1±22.4; 4 ‡29.9±
HOMA-IR 1.35±0.83 ‡1.64±
IGI †15.0±40.4 ¶15.8±
Total cholesterol, mg/dL †183.5±32.6 ‡192.5±
Triglycerides, mg/dL †124.3±67.7 ‡167.8±
HDL cholesterol, mg/dL †47.1±10.4 ‡44.0±
LDL cholesterol, mg/dL 111.6±29.4 115.2±
BMI=body mass index, DBP=diastolic blood pressure, HbA1c=glycated hemoglobin, HDL=high den
lipoprotein, IGI= insulinogenic index, KDS=Korean diabetes score, SBP= systolic blood pressure.
∗
P values were calculated from analysis of variance test for continuous variables and chi-squared test
a P< .05, jjP< .01, †P< .001 between nondiabetes and incident diabetes among individuals with KDS
# P< .05, ¶P< .01, ‡P< .001 between nondiabetes and incident diabetes among individuals with KDS
x P< .001 between individuals with non-diabetes and KDS≥5 versus individuals with incident diabetes
3markedly higher levels of HbA1c and fasting glucose. Moreover,
despite markedly lower HOMA-IR index (1.40 vs 1.64;
P< .001), individuals with KDS<5 and incident diabetes
presented with signiﬁcant lower levels of fasting insulin (6.6 vs
8.0mIU/mL; P<.001) and IGI (7.0 vs 15.8; P< .001) relative to
individuals with KDS≥5 but who ultimately did not develop
diabetes. In particular, levels of fasting insulin and IGI in subjects
with KDS<5 but who ultimately developed diabetes were the
lowest among 4 groups in Table 1.3.2. Relationship between KDS and incident diabetes
Figure 1 illustrates that the proportion of incident diabetes over
10 years gradually increased as KDS scores rose. The mean
prevalence of incident diabetes is 10.3% in participants with a
KDS<5 and is 21.8% in those with KDS≥5 (P< .001). Based on
the KDS cutoff point of 5, participants with KDS≥5 had a
markedly increased cumulative incidence of diabetes compared to
those with KDS<5 (Fig. 2; P< .001 by log-rank test).
To test the independent association between KDS score and
incident diabetes over 10 years, we performed Cox proportional
hazards analysis and variables such as age, smoking and alcohol
consumption, and family history of diabetes that were composed
of KDS, were excluded in covariates in the analysis (Table 2). A
1-point increase in KDS score presented a signiﬁcantly elevated
adjusted hazard ratio (HR) for incident diabetes after adjusting
for sex, exercise status, levels of HbA1c, fasting glucose, postload
2-hour glucose, total cholesterol, triglyceride, HDL cholesterol,
IGI, and HOMA-IR index (HR:1.13; 95% conﬁdence interval
[CI]:1.09–1.18; P< .001). In addition, male sex, levels of HbA1c,
fasting glucose, postload 2-hour glucose, triglyceride, and IGI
were signiﬁcant determinants of incident diabetes.the development of diabetes (N=8735).
Incident diabetes (N=1513)
=4183) KDS<5 (N=349) KDS≥5 (N=1164)
∗
P
8.6 x50.3±8.6 54.4±8.5 <.001
(54.1) #160 (45.8) 573 (49.2) <.001
7.0 x76.2±5.3 87.8±7.2 <.001
2.9 x22.9±2.3 26.1±3.0 <.001
(56.8) x62 (16.9) 716 (62.8) <.001
(37.0) x61 (17.5) 563 (48.4) <.001
17.9 x119.0±18.7 128.7±17.8 <.001
11.2 x78.8±10.9 84.7±10.8 <.001
1.6) 46 (13.2) 156 (13.4) <.001
58.7/12.6/28.7) x195/92/62 (55.9/26.4/17.8) 628/184/352 (54.0/15.8/30.2) <.001
74.9/19.1/6.0) x304/44/1 (87.1/12.6/0.3) 835/260/69 (71.7/22.3/5.9) <.001
73.5/19.3/7.2) 253/64/32 (72.5/18.3/9.2) 848/214/102 (72.9/18.4/8.8) .244
(37.5) x34 (9.7) 603 (51.8) <.001
0.4 x5.7±0.4 5.9±0.5 <.001
8.4 x86.1±10.2 88.0±10.5 <.001
28.5 x134.1±32.5 137.7±33.7 <.001
5.1 x6.6±2.9 8.5±5.0 <.001
29.5 28.6±24.2 35.6±31.8 <.001
1.07 x1.40±0.65 1.86±1.15 <.001
43.3 #7.0±9.6 11.0±45.4 <.001
35.5 191.6±35.0 198.1±34.4 <.001
101.7 159.4±90.9 196.7±121.8 <.001
9.9 45.0±10.2 42.5±9.2 <.001
33.5 114.2±32.7 115.3±33.2 <.001
sity lipoprotein, HOMA-IR=homeostasis model assessment of insulin resistance, LDL= low density
s for categorical variables, respectively.
<5.
≥5.
and KDS<5.
Figure 1. Relationship between Korean Diabetes Score and the development
of diabetes over 10 years.
Table 2
Association of KDS with the incidence of diabetes in the Cox
proportional hazards models.
HR 95% CI P
KDS, per 1 point 1.13 1.09–1.18 <.001
Sex (0=male, 1= female) 0.85 0.76–0.96 .010
BMI, per 1 kg/m2 1.00 0.98–1.02 .804
Exercise, none/wk Referent
Exercise, 1–3 times/wk 0.94 0.82–1.09 .413
Exercise, ≥4 times/wk 1.00 0.82–1.22 .985
HbA1c, per 1% 2.57 2.25–2.94 <.001
Fasting glucose, per 10mg/dL 1.29 1.21–1.38 <.001
Postload 2-h glucose, per 10mg/dL 1.20 1.17–1.22 <.001
Total cholesterol, per 10mg/dL 0.99 0.97–1.01 .139
Triglyceride, per 10mg/dL 1.01 1.01–1.02 <.001
HDL cholesterol, per 5mg/dL 0.97 0.94–1.01 .107
∗
IGI 0.93 0.89–0.97 .001
∗
HOMA-IR index 1.01 0.91–1.11 .916
Bold font indicates the HR is signiﬁcantly elevated. CI= conﬁdence interval; HDL=high density
lipoprotein; HOMA-IR=homeostasis model assessment of insulin resistance; HR=hazard ratio; IGI=
insulinogenic index; KDS=Korean Diabetes Score.
∗
Variables are log-transformed.
Kim et al. Medicine (2017) 96:23 MedicineFurther, we investigated the performance of KDS in addition to
different risk factors for the prediction of incident diabetes over
10 years by ROC analyses. As shown in Table 3, the AUC of the
univariate logistic model of KDS score was 0.641 (95% CI,
0.627–0.656) and it increased to 0.780 (95%CI, 0.767–0.793) in
the multivariate comprehensive model of KDS, fasting glucose,
HbA1c, and postload 2-hour glucose. The multivariate combi-
nation model of KDS in addition to fasting glucose, HbA1c,
postload 2-hour glucose, and triglyceride showed the highest
AUC of 0.782 (95% CI 0.769–0.795). The performance of other
risk scores including US screening score,[27] Thai score,[28] and
Rotterdammodel,[29] revealed AUCs ranged from 0.579 to 0.643
(Supplementary table 1, http://links.lww.com/MD/B726).Figure 2. Ten-year diabetes-free survival according to baseline Korean
Diabetes Score (<5 or ≥5). KDS = Korean Diabetes Score.
4To investigate whether KDS score reﬂects components of
insulin resistance or beta-cell function, we analyzed AUCs of risk
models of HOMA-IR or IGI for predicting KDS≥5 (Supplemen-
tary table 2, http://links.lww.com/MD/B726). An AUC of 0.613
(95% CI 0.601–0.625) with HOMA-IR index was higher than
IGI (AUC, 0.476; 95% CI, 0.462–0.490), indicating KDS might
represent an insulin resistance component more than beta-cell
function. In subgroup analyses of age, individuals younger than
50 years revealed markedly higher values of AUCs than those
older than 50 years for predicting incident diabetes in all of these
models.3.3. Predictive parameters for incident diabetes according
to KDS
We further evaluated signiﬁcant clinical and laboratory param-
eters to predict the likelihood of developing diabetes during 10
years of follow-up in participants having KDS<5 at baseline
(Table 4). Cox proportional hazards analysis showed that
systolic blood pressure (SBP), family history of diabetes, HbA1c,
fasting glucose, postload 2-hour glucose, triglyceride, and IGI
were independently associated with incident diabetes in subjects
with KDS<5 at baseline. In addition, a family history of diabetes,
current smoking, increased SBP, HbA1c, fasting glucose, post-
load 2-hour glucose, triglyceride, and decreased IGI were
signiﬁcant predictors of an increased likelihood of incident
diabetes in subjects having baseline KDS≥5. Collectively,
common independent parameters for predicting diabetes were
the presence of family history of diabetes, increased SBP, HbA1c,
fasting glucose, postload 2-hour glucose, and decrease in IGI,
which indicates decline in beta-cell function.4. Discussion
In the present study, we investigated and validated the KDS to
predict diabetes in a 10-year longitudinal data. We conﬁrmed
that subjects with a baseline KDS≥5were signiﬁcantly associated
with a high incidence of diabetes, and that the KDS risk model
becomes more potent in combination with various laboratory
parameters. In particular, there is an increased ability to predict
Table 3
Comparisons of riskmodels of Korean Diabetes Score and various
laboratory parameters for predicting diabetes.
AUC 95% CI P
KDS 0.641 0.627–0.656 <.001
Fasting glucose 0.660 0.644–0.676 <.001
HbA1c 0.695 0.680–0.710 <.001
Postload 2-h glucose 0.722 0.707–0.737 <.001
TG 0.638 0.623–0.653 <.001
HOMA-IR index 0.579 0.562–0.595 <.001
IGI 0.604 0.587–0.620 <.001
KDS+ fasting glucose 0.701 0.687–0.715 <.001
KDS+HbA1c 0.719 0.701–0.733 <.001
KDS+postload 2-h glucose 0.751 0.737–0.764 <.001
KDS+TG 0.665 0.651–0.680 <.001
KDS+ fasting glucose+postload 2-h glucose 0.765 0.752–0.779 <.001
KDS+ fasting glucose+HbA1c+postload 2-h
glucose
0.780 0.767–0.793 <.001
KDS+ fasting glucose+HbA1c+postload 2-h
glucose+TG
0.782 0.769–0.795 <.001
Fasting glucose+HbA1c+postload 2-h
glucose+TG
0.772 0.758–0.785 <.001
Subgroup analysis
Age 50 years (n=4605)
KDS 0.656 0.635–0.677 <.001
KDS+ fasting glucose+postload 2-h
glucose
0.784 0.764–0.803 <.001
KDS+ fasting glucose+HbA1c+postload
2-h glucose
0.798 0.779–0.817 <.001
KDS+ fasting glucose+HbA1c+postload
2-h glucose+TG
0.800 0.782–0.819 <.001
Age >50 years (n=4130)
KDS 0.611 0.590–0.632 <.001
KDS+ fasting glucose+postload 2-h
glucose
0.739 0.719–0.758 <.001
KDS+ fasting glucose+HbA1c+postload
2-h glucose
0.753 0.734–0.771 <.001
KDS+ fasting glucose+HbA1c+postload
2-h glucose+TG
0.755 0.737–0.774 <.001
AUC= area under the receiver-operating characteristic curve, CI= conﬁdence interval, HOMA-IR=
homeostasis model assessment of insulin resistance, IGI= insulinogenic index, KDS=Korean
Diabetes Score, TG= triglyceride.
Kim et al. Medicine (2017) 96:23 www.md-journal.comdiabetes using the KDS in participants younger than 50 years
compared to those over 50 years. In addition, low IGI,
representing impaired beta-cell function, was an independent
determinant of incident diabetes in low-risk individuals with
baseline KDS<5.
Every 1-point increase in the KDS revealed a signiﬁcantly
increased risk of developing diabetes.Moreover, levels of HbA1c,
fasting glucose, postload 2-hour glucose, and triglyceride were
also shown as strong predictors for diabetes in this study, as
previously suggested.[30–33] IGI and HOMA-IR index were
included as covariates in the analyses, but only low IGI was
shown as an independent risk factor for incident diabetes
(Table 2). Consistent with this, baseline clinical and laboratory
characteristics revealed that subjects with a baseline KDS<5who
ultimately developed diabetes had the lowest fasting insulin levels
and IGI, but lower HOMA-IR index, compared to those having
baseline KDS≥5 but who did not develop diabetes. Moreover,
Cox regression analysis in participants having a baseline KDS<5
who developed diabetes showed that a low level of IGI was a
signiﬁcant predictor of diabetes. These ﬁndings indicate that
impaired beta-cell function at baseline but not insulin resistance is5a signiﬁcant determinant in the development of diabetes in the
Korean population. Our study results are in line with previous
studies regarding the role of beta-cell dysfunction, especially in
Asian populations.[34,35] Decreased beta-cell function was shown
to be the major determinant for the development of type 2
diabetes, which limits compensation in response to minor
progressive insulin resistance in Asians; otherwise, a compensa-
tory increase of beta-cell function was revealed with deeply
declined insulin sensitivity in White people.[13,35,36] Consistent
with this, compared to HOMA-IR index (AUC, 0.579; 95% CI,
0.562–0.595), IGI presented a higher AUC of 0.604 (95% CI,
0.587–0.620) in predicting diabetes (Table 3). Further, we
evaluated independent factors to predict incident diabetes in
people with baseline KDS≥5 who ultimately developed diabetes
using the Cox regression model, and also found that low IGI was
an independent predictor. In particular, current smoking had a
signiﬁcant adjusted HR of 1.49 (95% CI, 1.19–1.87) for the risk
of diabetes in participant having baseline KDS≥5; therefore, as a
modiﬁable risk factor, smoking cessation should be emphasized
to people with baseline KDS score ≥5.
In terms of the AUC, the KDS demonstrated a modest level of
accuracy in predicting diabetes (0.641; 95% CI, 0.627–0.656)
with a sensitivity of 61% and a speciﬁcity of 61%. Other risk
scores including Thai score, Rotterdam model, and US screening
score had AUCs ranged from 0.579 to 0.643 with the sensitivities
from 63% to 77% and the relatively low speciﬁcities from 36%
to 57%. In the previous study regarding performance of the KDS
risk model using cross-sectional data,[15] the KDS had an AUC of
0.730 with a cut point of KDS≥5. Also, a recent study reported
an AUC of 0.696 (95% CI, 0.655–0.737) among 3029
individuals with a mean follow-up period of 6.2 years, in which
the deﬁnition of diabetes was different (e.g., fasting glucose ≥126
mg/dL or HbA1c≥6.5%) from the present study.[37] In the
present study, the risk prediction model for diabetes performed
better up to an AUC of 0.782 (95% CI, 0.769–0.795) with a
sensitivity of 69% and a speciﬁcity of 74% in the comprehensive
risk model of KDS combined with laboratory parameters,
including concentrations of fasting glucose, HbA1c, postload 2-
hour glucose, and triglyceride. Our 10-year longitudinal results
revealed lower AUCs compared to a previous study with cross-
sectional data or a shorter follow-up period.[37] The tendency
toward lower AUC values in longitudinal data compared to those
in cross-sectional data was also seen in the previous study. This
might be affected by an insufﬁciency of KDS for representing
beta-cell function rather than insulin sensitivity, because
impaired beta-cell function is more dependent than insulin
resistance in the predisposition to diabetes in Asian people.[35]
Furthermore, because KDS is an effective primary screening tool
for predicting nonalcoholic fatty liver disease or nonalcoholic
steatohepatitis, which is strongly associated with insulin
resistance, this also revealed that the KDS strongly reﬂects
insulin sensitivity.[25] In line with this, in subgroup analyses, all of
the risk prediction models demonstrated higher accuracy in
predicting diabetes in people younger than 50 years, whose beta-
cell function is more preserved in general (IGI, 15.7 vs 13.3;
P= .014; HOMA-IR, 1.55 vs 1.57; P= .616; age50 years old vs
age >50 years old) compared to those older than 50 years.
The present study has several distinguishable strengths. It is the
ﬁrst study to investigate the ability of the KDS to predict incident
diabetes in a large population over 10 years of follow-up.
Therefore, we could analyze the real-world longitudinal results.
Further, we evaluated numerous risk prediction models with
laboratory parameters based on KDS to compare the likelihood
Table 4
Cox regression analysis of the variables associated with the development of diabetes among subjects according to KDS<5 and KDS≥5.
KDS<5 (total, N=3388; incident diabetes, N=349) KDS≥5 (total, N=5347; incident diabetes, N=1164)
HR 95% CI P HR 95% CI P
Age, y 1.05 0.99–1.02 .472 1.00 0.99–1.01 .976
Sex (0=male, 1= female) 1.05 0.73–1.52 .791 1.01 0.80–1.26 .974
BMI, per 1 kg/m2 1.01 0.95–1.08 .676 1.01 0.99–1.04 .322
SBP, per 5mm Hg 1.08 1.04–1.12 <.001 1.06 1.04–1.08 <.001
Family history of diabetes 1.82 1.29–2.57 .001 1.24 1.03–1.50 .023
Smoking, never Referent Referent
Smoking, past 1.39 0.95–2.05 .092 1.21 0.94–1.56 .132
Smoking, current 1.41 0.92–2.15 .116 1.49 1.19–1.87 .001
Exercise, none/wk Referent Referent
Exercise, 1–3 times/wk 0.85 0.63–1.15 .290 0.98 0.83–1.16 .813
Exercise, ≥4 times/wk 1.17 0.77–1.78 .469 1.01 0.80–1.28 .910
HbA1c, per 1% 2.66 1.92–3.67 <.001 2.58 2.22–3.01 <.001
Fasting glucose, per 10mg/dL 1.33 1.14–1.54 <.001 1.28 1.18–1.38 <.001
Postload 2-h glucose, per 10mg/dL 1.23 1.18–1.29 <.001 1.18 1.16–1.21 <.001
Total cholesterol, per 10mg/dL 0.99 0.96–1.04 .774 0.98 0.96–1.00 .086
Triglyceride, per 10mg/dL 1.02 1.01–1.03 .020 1.01 1.01–1.02 <.001
HDL cholesterol, per 10mg/dL 0.94 0.87–1.01 .078 0.98 0.94–1.02 .270
∗
IGI 0.88 0.81–0.96 .005 0.94 0.89–0.99 .023
∗
HOMA-IR index 1.02 0.83–1.27 .843 0.99 0.89–1.11 .898
Bold font indicates the HR is signiﬁcantly elevated. CI=conﬁdence interval, HDL=high density lipoprotein, HOMA-IR=homeostasis model assessment of insulin resistance, HR=hazard ratio, IGI= insulinogenic
index, KDS=Korean Diabetes Score, SBP= systolic blood pressure.
∗
Variables are log-transformed.
Kim et al. Medicine (2017) 96:23 Medicineof predicting diabetes. The KDS is a simple and easy self-
assessment tool for laypersons without any mathematical
calculations, blood assays, or expense, in the prediction of
diabetes. The KDS includes only 6 easily comprehensible
components such as age, waist circumference, family history of
diabetes, hypertension, smoking status, and daily alcohol
consumption. Therefore, the KDS is not only a convenient tool
but also a practical tool with which laypersons can self-assess
their risk factors for diabetes and improve their health status with
checking modiﬁable risk factors related to personal lifestyle.
Second, participants with incident diabetes were in addition
deﬁned by a 2-hour 75-g OGTT, which was performed
biannually for all participants. Moreover, insulin resistance
and beta-cell function, 2 main components in the development of
diabetes, could be assessed asHOMA-IR and IGI, respectively, so
the relationship between the KDS and the development of
diabetes regarding insulin resistance or beta-cell function could
be evaluated.
Nonetheless, there are limitations in the present study. Despite
a large number of 10,030 participants in KoGES, age ranged
from 40 to 69 years in a community-based cohort. Therefore,
subjects aged under 40 years or over 70 years were not included,
which limits our results to generalization. However, we
performed subgroup analyses by age under or over 50 years to
verify the performance of the KDS risk prediction models for
incident diabetes. As the components of KDS could be related to
the bias when using subgroup analysis with participants having
KDS<5 or ≥5 at baseline, we checked the multicollinearity and
found that there was no multicollinearity among these
parameters including KDS score. Moreover, for log-transformed
in IGI values, negative IGI values were regarded as missing,
similar to the previous study,[35] which might cause potential bias
in the study. In addition, as 5544 (55.3%) subjects completed the
study up to Year 10 from the 10,030 participants of the cohort at
baseline,[16,35] the attrition bias could be existed in the analysis of
the present study.6In conclusion, we investigated and validated the KDS in a well-
designed cohort over 10 years and found that additional KDS
combined with various laboratory parameters may be more
effective for predicting diabetes than KDS alone. Furthermore,
beta-cell function is a crucial independent determinant for
developing diabetes in Koreans, which alsomay be considered for
diabetes risk prediction when estimated using KDS.Acknowledgments
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